These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21036803)

  • 1. Images in cardiology. The traumatic effect of balloon dilatation on neointimal hyperplasia: what we did not see before optical coherence tomography.
    Picchi A; Micheli A; Limbruno U
    Heart; 2011 Feb; 97(3):265-6. PubMed ID: 21036803
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual-catheter covered stenting: a novel approach to the treatment of large coronary artery perforations.
    Silver KH; Bauman WB; Berkovitz KE
    J Invasive Cardiol; 2003 Jun; 15(6):348-50. PubMed ID: 12777675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.
    Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P
    Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of acute vessel wall injury after self-expanding stent and conventional balloon-expandable stent implantation: a study with optical coherence tomography.
    Shin ES; Garcia-Garcia HM; Okamura T; Wykrzykowska JJ; Gonzalo N; Shen ZJ; van Geuns RJ; Regar E; Serruys PW
    J Invasive Cardiol; 2010 Sep; 22(9):435-9. PubMed ID: 20814052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis.
    Yoneyama K; Koyama K; Tanabe Y; Mitarai T; Kamijima R; Kuwata S; Yamazaki H; Nakano E; Kongoji K; Harada T; Akashi YJ
    Int J Cardiol; 2014 Oct; 176(3):1207-9. PubMed ID: 25129263
    [No Abstract]   [Full Text] [Related]  

  • 6. Optical coherence tomography: a new tool to detect tissue coverage in drug-eluting stents.
    Di Mario C; Barlis P
    JACC Cardiovasc Interv; 2008 Apr; 1(2):174-5. PubMed ID: 19463296
    [No Abstract]   [Full Text] [Related]  

  • 7. Images in cardiovascular medicine. In-stent neointimal hyperplasia with 16-row multislice computed tomography coronary angiography.
    Mollet NR; Cademartiri F
    Circulation; 2004 Nov; 110(21):e514. PubMed ID: 15557383
    [No Abstract]   [Full Text] [Related]  

  • 8. Catheter entrapment during balloon angioplasty in patient with in-stent restenosis: an unusual complication and its surgical management.
    Goksin I; Baltalarli A; Semiz E; Gurses E; Sacar M; Ozcan V; Sungurtekin H
    J Card Surg; 2007; 22(2):160-2. PubMed ID: 17338758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of fragmented balloon materials in coronary arteries by optical coherence tomography.
    Adoni NA; Huang GW; Rangasetty UC; Gilani S; Fujise K
    JACC Cardiovasc Interv; 2014 Jun; 7(6):e65-6. PubMed ID: 24947730
    [No Abstract]   [Full Text] [Related]  

  • 11. Unexpected adverse effects of coronary brachytherapy remote from intended target.
    Baweja G; Kamineni R; Butman S
    J Invasive Cardiol; 2005 Feb; 17(2):94-5. PubMed ID: 15687533
    [No Abstract]   [Full Text] [Related]  

  • 12. Impending coronary perforation after cutting balloon angioplasty.
    Ako J; Honda Y; Fitzgerald PJ
    Heart; 2005 Jan; 91(1):e8. PubMed ID: 15604315
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
    Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus.
    Kaneda H; Ako J; Kataoka T; Takahashi T; Terashima M; Waseda K; Miyazawa A; Hassan A; Honda Y; Yock PG; Fitzgerald PJ
    Am J Cardiol; 2006 Feb; 97(3):340-2. PubMed ID: 16442392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography to diagnose under-expansion of a drug-eluting stent.
    Motreff P; Souteyrand G
    JACC Cardiovasc Imaging; 2009 Feb; 2(2):245-6; author reply 246. PubMed ID: 19356563
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation.
    Suzuki Y; Ikeno F; Koizumi T; Tio F; Yeung AC; Yock PG; Fitzgerald PJ; Fearon WF
    JACC Cardiovasc Interv; 2008 Apr; 1(2):168-73. PubMed ID: 19463295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of OCT in evaluating neointimal thickness after stent implantation.
    Ferrante G; Dimopoulos K; Montone RA; Barlis P
    JACC Cardiovasc Imaging; 2010 Jun; 3(6):669; discussion 669-70. PubMed ID: 20541723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.